Ayurveda is going global—and Kapiva is leading the charge. The nutrition and wellness brand has just raised $60 million in Series D funding, putting it firmly on the radar of investors betting big on the future of health and wellness. The round was co-led by 360 ONE Asset and Vertex Growth, with continued backing from Vertex Ventures Southeast Asia & India and 3one4 Capital.
But there’s more: the deal wasn’t just about raising capital. About $28 million came in as fresh growth investment, while the rest allowed early backer Fireside Ventures to make a full exit. That makes this raise a milestone—not only for Kapiva’s journey but also for India’s consumer startup ecosystem, where the first generation of investors is now cashing out with significant gains.
Credits: Ascendants
What Will Kapiva Do With $60 Million?
Kapiva isn’t treating this fundraise as just more money in the bank—it’s fuel for a bigger mission. A chunk of the capital will go toward research and development, ensuring every product stands tall on scientific validation. For a wellness brand built on Ayurveda, this credibility is the bridge to win both Indian and global consumers.
The company is also scaling its manufacturing to keep up with soaring demand while holding quality steady. On the branding side, expect Kapiva to turn up the volume on marketing campaigns, making its products even more visible in a crowded nutraceutical space.
Perhaps most exciting is its plan to supercharge its health-tech platform. Imagine Ayurveda meeting digital tools for personalized wellness journeys—helping people not just buy supplements but also manage chronic conditions and track long-term health. That’s where Kapiva wants to play big.
From Juices to Proteins: The Kapiva Universe
Founded in 2015 by Ameve Sharma and Shrey Badhani, Kapiva was built on a simple idea: make Ayurveda modern, convenient, and relevant. Today, its product line spans herbal juices, teas, vegan proteins, oils, and targeted supplements for issues ranging from diabetes and liver health to hormonal balance.
And it’s not just online hype. Kapiva has cracked the offline game too, with products available across 40,000 stores in India. By blending D2C strength with physical presence, Kapiva ensures consumers can discover its products wherever they shop. This omnichannel muscle is a major growth lever—one that many startups struggle to build.
Numbers That Speak for Themselves
Kapiva’s growth has been nothing short of explosive. In FY24, it doubled its revenue to ₹228 crore while narrowing losses to ₹56 crore. Today, it’s operating at a revenue run rate of nearly ₹550 crore and is on track to hit profitability next quarter.
For investors, this combination of high growth and a near-profitable model makes Kapiva a rare gem in the D2C world. It’s proof that Ayurveda, when done right, isn’t just tradition—it’s a serious business opportunity.
Standing Out in a Crowded Market
Of course, Kapiva isn’t alone. It competes with legacy names and new-age challengers like Wellbeing Nutrition, Gynoveda, and Innovacare. In such a crowded space, trust, differentiation, and scientific proof are the real battlegrounds.
Kapiva’s edge lies in positioning itself as a science-backed Ayurveda brand. If it can keep innovating and navigating tricky regulatory waters, it has the potential to stay ahead of the pack and claim leadership in this booming sector.
Going Global—and Maybe Public
Kapiva isn’t just eyeing India. It’s already selling in the U.S., Middle East, and Europe, with the American market showing early traction through a wholly owned subsidiary. Global wellness trends are tilting toward holistic solutions, and Ayurveda is increasingly part of that conversation.
Industry watchers say this Series D could be Kapiva’s last big private raise before it considers an IPO in 2–3 years. A listing would mark a turning point, positioning Kapiva as one of India’s first modern Ayurveda brands to go public.
Credits: DealStreetAsia
The Road Ahead
Kapiva is at a fascinating crossroads. Backed by fresh funds, it now has the resources to innovate, expand globally, and build a tech-driven wellness ecosystem. But the real test lies ahead—can it turn Ayurveda into a global, science-backed lifestyle movement while keeping profitability intact?
If it succeeds, Kapiva won’t just be another D2C brand—it could become the company that put modern Ayurveda on the world map. For now, its $60 million war chest is ready to make that vision a reality.
